Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,985 | 256 | 99.9% |
| Education | $4.50 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,024 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $561.58 | 25 | $0 (2024) |
| LEO Pharma Inc. | $509.38 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $476.54 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $380.03 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $313.77 | 15 | $0 (2024) |
| PFIZER INC. | $251.01 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $213.27 | 5 | $0 (2024) |
| Genentech USA, Inc. | $191.80 | 10 | $0 (2020) |
| GENZYME CORPORATION | $163.07 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,150 | 39 | Regeneron Healthcare Solutions, Inc. ($234.45) |
| 2023 | $891.03 | 34 | E.R. Squibb & Sons, L.L.C. ($211.08) |
| 2022 | $678.58 | 30 | E.R. Squibb & Sons, L.L.C. ($116.18) |
| 2021 | $615.76 | 23 | AbbVie Inc. ($361.75) |
| 2020 | $437.33 | 15 | Novartis Pharmaceuticals Corporation ($152.15) |
| 2019 | $737.47 | 37 | Genentech USA, Inc. ($144.45) |
| 2018 | $633.20 | 36 | LEO Pharma Inc. ($98.30) |
| 2017 | $845.89 | 43 | Actelion Pharmaceuticals US, Inc. ($115.63) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Celgene Corporation | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: Immunology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.48 | General |
| 10/01/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Inflammation & Immunology | ||||||
| 09/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.75 | General |
| 09/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Immunology | ||||||
| 07/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Inflammation & Immunology | ||||||
| 07/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $106.62 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Dermatology | ||||||
| 06/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $98.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $131.25 | General |
| Category: Immunology | ||||||
| 05/15/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Dermatology | ||||||
| 05/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,976 | 8,688 | $1.3M | $422,684 |
| 2022 | 26 | 4,253 | 9,042 | $1.5M | $472,717 |
| 2021 | 36 | 4,866 | 9,370 | $1.6M | $546,559 |
| 2020 | 40 | 4,690 | 9,316 | $1.6M | $511,809 |
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 810 | 1,625 | $274,625 | $102,186 | 37.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 574 | 913 | $317,724 | $65,894 | 20.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 600 | 1,144 | $152,152 | $42,064 | 27.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 86 | 128 | $76,800 | $39,080 | 50.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 167 | 225 | $65,700 | $29,206 | 44.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 88 | 94 | $47,846 | $22,053 | 46.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 297 | 511 | $102,348 | $19,959 | 19.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 465 | 3,017 | $39,221 | $15,144 | 38.6% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 86 | 111 | $22,866 | $11,670 | 51.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 110 | 122 | $52,826 | $11,296 | 21.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 89 | 111 | $26,529 | $10,735 | 40.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 180 | 219 | $15,549 | $9,177 | 59.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 46 | 57 | $16,929 | $7,315 | 43.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 62 | 66 | $27,060 | $5,906 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 71 | $12,567 | $5,820 | 46.3% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 35 | 38 | $10,488 | $4,577 | 43.6% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 25 | 26 | $8,190 | $3,752 | 45.8% |
| 69100 | Biopsy of ear | Office | 2023 | 49 | 55 | $9,625 | $2,967 | 30.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $5,357 | $2,609 | 48.7% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 28 | 28 | $6,524 | $2,588 | 39.7% |
| 67810 | Biopsy of eyelid | Office | 2023 | 14 | 15 | $5,325 | $2,042 | 38.4% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $3,900 | $1,685 | 43.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 28 | 43 | $4,042 | $1,373 | 34.0% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $5,111 | $1,328 | 26.0% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $5,964 | $1,209 | 20.3% |
About Dr. Richard Kirkpatrick, MD
Dr. Richard Kirkpatrick, MD is a Dermatology healthcare provider based in Rockledge, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821074980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Kirkpatrick, MD has received a total of $5,990 in payments from pharmaceutical and medical device companies, with $1,150 received in 2024. These payments were reported across 257 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,985).
As a Medicare-enrolled provider, Kirkpatrick has provided services to 17,785 Medicare beneficiaries, totaling 36,416 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Rockledge, FL
- Active Since 12/21/2005
- Last Updated 12/03/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1821074980
Products in Payments
- SKYRIZI (Biological) $692.46
- DUPIXENT (Biological) $394.77
- COSENTYX (Biological) $392.52
- Sotyktu (Drug) $275.45
- ENSTILAR (Drug) $250.31
- ADBRY (Biological) $212.22
- Erivedge (Biological) $191.80
- LIBTAYO (Biological) $180.15
- Humira (Biological) $174.94
- TREMFYA (Drug) $174.52
- BLU-U (Medical Supply) $169.93
- EUCRISA (Drug) $165.72
- VTAMA (Drug) $132.57
- COSENTYX (Drug) $129.76
- OPDIVO (Biological) $124.46
- Otezla (Drug) $122.38
- HUMIRA (Biological) $116.81
- VALCHLOR MECHLORETHAMINE (Drug) $115.63
- TALTZ (Drug) $112.36
- CIBINQO (Drug) $85.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.